GAGLIARDI, DELIA
GAGLIARDI, DELIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience
2024 D. Gagliardi, E. Canzio, P. Orsini, P. Conti, V. Sinisi, C. Maggiore, M. Carla Santarsia, G. Lagioia, G. Lupis, I. Roppa, G. Scianatico, D. Mancini, S. Corti, G.P. Comi, M. Gentile, D. Gagliardi
Unleashing the potential of mRNA therapeutics for inherited neurological diseases
2024 E. Monfrini, G. Baso, D. Ronchi, M. Meneri, D. Gagliardi, L. Quetti, F. Verde, N. Ticozzi, A. Ratti, A. Di Fonzo, G.P. Comi, L. Ottoboni, S. Corti
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
2023 M. Meneri, E. Abati, D. Gagliardi, I. Faravelli, V. Parente, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, L. Ottoboni, S. Corti
Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
2023 D. Gagliardi, P. Ripellino, M. Meneri, R. Del Bo, S. Antognozzi, G.P. Comi, C. Gobbi, A. Ratti, N. Ticozzi, V. Silani, D. Ronchi, S. Corti
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis
2023 A. Maranzano, F. Verde, E. Colombo, B. Poletti, A. Doretti, R. Bonetti, D. Gagliardi, M. Meneri, L. Maderna, S. Messina, S. Corti, C. Morelli, V. Silani, N. Ticozzi
NOTCH2NLC GGC repeats are not expanded in Italian amyotrophic lateral sclerosis patients
2023 A. Manini, D. Gagliardi, M. Meneri, S. Antognozzi, R. Del Bo, G.P. Comi, S. Corti, D. Ronchi
The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis
2023 E. Colombo, F. Gentile, A. Maranzano, A. Doretti, F. Verde, M. Olivero, D. Gagliardi, M. Faré, M. Meneri, B. Poletti, L. Maderna, S. Corti, M. Corbo, C. Morelli, V. Silani, N. Ticozzi
Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study
2023 I. Faravelli, D. Gagliardi, E. Abati, M. Meneri, J. Ongaro, F. Magri, V. Parente, L. Petrozzi, G. Ricci, F. Farè, G. Garrone, M. Fontana, D. Caruso, G. Siciliano, G.P. Comi, A. Govoni, S. Corti, L. Ottoboni
Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
2023 E. Colombo, A. Doretti, F. Scheveger, A. Maranzano, G. Pata, D. Gagliardi, M. Meneri, S. Messina, F. Verde, C. Morelli, S. Corti, L. Maderna, V. Silani, N. Ticozzi
Genomic and transcriptomic advances in amyotrophic lateral sclerosis
2023 M. Rizzuti, L. Sali, V. Melzi, S. Scarcella, G. Costamagna, L. Ottoboni, L. Quetti, L. Brambilla, D. Papadimitriou, F. Verde, A. Ratti, N. Ticozzi, G.P. Comi, S. Corti, D. Gagliardi
Newly Diagnosed Hepatic Encephalopathy Presenting as Non-convulsive Status Epilepticus: A Case Report and Literature Review
2022 M. Olivero, D. Gagliardi, G. Costamagna, D. Velardo, F. Magri, F. Triulzi, G. Conte, G.P. Comi, S. Corti, M. Meneri
New Insights into Cerebral Vessel Disease Landscapes at Single-Cell Resolution: Pathogenetic and Therapeutic Perspectives
2022 M. Meneri, S. Bonato, D. Gagliardi, G.P. Comi, S. Corti
Analysis of miRNA rare variants in amyotrophic lateral sclerosis and in silico prediction of their biological effects
2022 A. Brusati, A. Ratti, V. Pensato, S. Peverelli, D. Gentilini, E. Dalla Bella, M.N. Sorce, M. Meneri, D. Gagliardi, S. Corti, C. Gellera, G. Lauria Pinter, N. Ticozzi, V. Silani
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Analysis of HTT CAG repeat expansion in Italian patients with amyotrophic lateral sclerosis
2022 A. Manini, D. Gagliardi, M. Meneri, S. Antognozzi, R. Del Bo, C. Scaglione, G.P. Comi, S. Corti, D. Ronchi
MicroRNAs as serum biomarkers in Becker muscular dystrophy
2022 D. Gagliardi, M. Rizzuti, R. Brusa, M. Ripolone, S. Zanotti, E. Minuti, V. Parente, L. Dioni, S. Cazzaniga, P. Bettica, N. Bresolin, G.P. Comi, S. Corti, F. Magri, D. Velardo
Homozygous SOD1 Variation L144S Produces a Severe Form of Amyotrophic Lateral Sclerosis in an Iranian Family
2022 D. Gagliardi, M. Ahmadinejad, R. Del Bo, M. Meneri, G.P. Comi, S. Corti, D. Ronchi
Targeting PTB for Glia‐to‐Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
2022 M. Contardo, R. De Gioia, D. Gagliardi, G.P. Comi, L. Ottoboni, M. Nizzardo, S. Corti
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
2022 M. Rizzuti, V. Melzi, D. Gagliardi, D. Resnati, M. Meneri, L. Dioni, P. Masrori, N. Hersmus, K. Poesen, M. Locatelli, F. Biella, R. Silipigni, V. Bollati, N. Bresolin, G.P. Comi, P. Van Damme, M. Nizzardo, S. Corti
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
2022 A.G. Thompson, E. Gray, N. Verber, Y. Bobeva, V. Lombardi, S.R. Shepheard, O. Yildiz, E. Feneberg, L. Farrimond, T. Dharmadasa, P. Gray, E.C. Edmond, J. Scaber, D. Gagliardi, J. Kirby, T.M. Jenkins, P. Fratta, C.J. Mcdermott, S.G. Manohar, K. Talbot, A. Malaspina, P.J. Shaw, M.R. Turner